| View Larger Image | Biomarker Methods in Drug Discovery and Development (Methods in Pharmacology and Toxicology) | Hardcoverby Feng Wang (Editor)
| List Price: | $129.00 | | Price: | $102.77 | | You Save: | $26.23 (20%) | | | Available: | Usually ships in 24 hours |
| | Binding: | Hardcover | | Publisher: | Humana Press | | Edition: | 1st Edition | | Page Count: | 396 Pages | | Publication Date: | March 11, 2008 | | Sales Rank: | 1,727,331st |
|
EDITORIAL REVIEWS |
Product Description
Within the pharmaceutical industry, the improvement of drug discovery and development efficiency and the expected personalization of medicine have become vitally important issues. In Biomarker Methods in Drug Discovery and Development, expert researchers provide a tool box for those who have a general interest in biomarker research and for those currently specializing in certain technologies but desiring an understanding of other available methodologies. Its chapters include validated, mature methods as well as new, incredibly promising protocols which aim to apply multiple technologies at different molecular levels in order to surmount the monumental and complex task of transforming the pharmaceutical research and development processes. As a volume in the Methods in Pharmacology and Toxicology™ series, this book offers user-friendly, step-by-step laboratory protocols for readily reproducible experiments. Comprehensive and state-of-the-art, Biomarker Methods in Drug Discovery and Development is the perfect biomarker technical guideline and reference to stimulate more exciting biomarker research and technology development. |
SIMILAR PRODUCTS |
| Biomarkers of Disease: An Evidence-Based Approach
by Andrew K. Trull (Editor), Lawrence M. Demers (Editor), David W. Holt (Editor), Atholl Johnston (Editor), J. Michael Tredger (Editor), Christopher P. Price (Editor)
This new publication takes a critical, evidence-based look at the efficacy of new diagnostic tests which are increasingly being used to evaluate organ damage and dysfunction. The use of biomarkers is growing, with a steady stream of new products being brought out by the pharmaceutical industry. However, in many cases the evidence which supports the use of these new methods as opposed to traditional biochemical tests has not yet been demonstrated, and it is intended that this volume will help...
| 
| Data Manipulation with R (Use R)
by Phil Spector (Author)
Since its inception, R has become one of the preeminent programs for statistical computing and data analysis. The ready availability of the program, along with a wide variety of packages and the supportive R community make R an excellent choice for almost any kind of computing task related to statistics. However, many users, especially those with experience in other languages, do not take advantage of the full power of R. Because of the nature of R, solutions that make sense in other...
| 
| Drug-like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization
by Edward Kerns (Author), Li Di (Author)
Of the thousands of novel compounds that a drug discovery project team invents and that bind to the therapeutic target, typically only a fraction of these have sufficient ADME/Tox properties to become a drug product. Understanding ADME/Tox is critical for all drug researchers, owing to its increasing importance in advancing high quality candidates to clinical studies and the processes of drug discovery. If the properties are weak, the candidate will have a high risk of failure or be less...
| 
| IMMUNOBIOLOGY 7 PB (Janeway's Immunobiology) (Immunobiology: The Immune System (Janeway))
by Kenneth M. Murphy (Author), Paul Travers (Author), Mark Walport (Author)
Janeway's Immunobiology, Seventh Edition is an introductory text for use in immunology courses for undergraduates, graduate students and medical students. It guides the reader through the immune system in all its aspects - from the first engagement of innate immunity to the generation of the adaptive immune response and its clinical consequences. The Seventh Edition has been comprehensively updated throughout, and includes new information on topics such as NK cells, Toll-like receptors, AID,...
| 
| Drugs: From Discovery to Approval
by Rick Ng (Author)
“Concise and easy to read, the book quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs.” –Doody's Reviews, May 2009 "The second edition of a book that offers a user-friendly step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of preclinical trials." –Chemistry World, February 2009
The new edition of...
|
|
|
